Cell Invasion and Migration Assays Market, 2022-2035

Cell Invasion and Migration Assays Market, 2022-2035

According to the World Health Organization (WHO), cancer is the second leading causes of mortality worldwide. In this context, it is important to highlight that around 10 million cancer deaths are reported globally each year. Further, it is estimated that, by 2030, around 21.4 million new patients are likely to be diagnosed with cancer annually. In fact, the global cancer burden is likely to increase by 70%, over the next two decades. With an aim to counter the rising number of cancer cases across the globe, several pharmaceutical players have developed cell invasion and migration assays to expediate the diagnosis process. It is worth highlighting that early diagnosis of cancer helps the patients to respond to therapy in an effective manner, thereby, increasing the chances of survival. Considering the various advantages offered by these cell-based assays, researchers across the globe have undertaken several initiatives to use these platforms for the diagnosis of a myriad of disease indications. The advancements in various technologies have propelled life science companies to use these assays in the drug discovery process, to enable the identification of potential lead candidates.

Given their extensive utilization in various drug discovery, tumor study and screening applications, there has been a significant rise in the revenue generation potential associated with cell invasion and migration assay kits. The current market landscape is consolidated and primarily dominated by the presence of large players. It is also worth mentioning that over 900 patents related to the implementation of invasion and migration assays have been filed / granted in the past few years, demonstrating the continued innovation in this domain. Taking into consideration both historical and recent developments, it is evident that the cell invasion and migration assay kits market is anticipated to grow at a significant pace in the coming years.

SCOPE OF THE REPORT

The “Cell Invasion and Migration Assay Market by Type of Assay (Cell Invasion Assay and Cell Migration Assay), Application Areas (Drug Discovery, Screening and Tumor Study), Detection Method Used (Colorimetry and Fluorometry) and Key Geographical Regions (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World): Industry Trends and Global Forecasts, 2022 – 2035” report features an extensive study of the current market landscape and the likely future potential associated with the cell invasion and migration assay market, over the next decade. The study also includes a detailed analysis of key drivers and trends within this evolving market. Amongst other elements, the report features:

• A detailed overview of the current market landscape of companies engaged in offering cell invasion and migration assays based on several parameters, such as year of establishment, company size, location of headquarters, type of end-user (industry and non-industry).
• A detailed overview of the overall market landscape of cell invasion and migration assays, based on several relevant parameters, such as type of cell culture (adherent and suspension cell culture), type of assay (cell invasion and cell migration assay), number of wells (24-well, 32-well, 48-well, 96-well and 384-well), pore size of wells (3 µm, 5 µm , 8 µm , 9 µm and 12 µm), type of ECM coating (basement membrane extract, collagen I, collagen IV, fibronectin and laminin,), storage temperature (ultra-low, frozen, refrigerated and room temperature), application area (drug discovery, screening and tumor study), detection method used (colorimetry and fluorometry) and number of assays performed.
• An insightful product competitiveness analysis of cell invasion and migration assays, based on their supplier strength (in terms of years of experience and company size) and product portfolio strength (which takes into account type of cell culture, number of wells, type of ECM coating, kit components, application area, detection method used and number of assays performed).
• Elaborate profiles of cell-based assay providers (large and mid-sized companies, established before 2000). Each profile features a brief overview of the company, along with information on its product portfolio, recent developments and an informed future outlook.
• A detailed review of around 675 peer-reviewed, scientific articles related to research on cell invasion and migration assays, based on several relevant parameters, such as year of publication, type of publication, popular keywords, top journals, top institutes and top authors (in terms of number of articles published).
• An in-depth analysis of patents related to cell invasion and migration assays filed / granted since 2017, based on several relevant parameters, such as publication year, geographical location / patent jurisdiction, legal status, CPC symbols, emerging focus areas, type of applicant and leading players (in terms of number of patents filed / granted). In addition, it features a patent valuation analysis which evaluates the qualitative and quantitative aspects of the patents.
• A detailed review of academic grants that have been awarded to various research institutes for projects focused on cell invasion and migration, during the period, 2017-2022, based on several parameters, such as year of grant award, amount awarded, support period, type of funding institute center, support period, grant application, purpose of grant award, grant activity code, NIH spending category, study section involved, popular NIH departments, recipient organization, regional distribution of recipient organization. Further, the chapter also highlights the popular recipient organizations, (in terms of number of grants and amount awarded) and prominent program officers.
• A Bowman’s strategy clock framework to understand the pricing strategy of the cell invasion and migration assays offered by a company, along with its competitive position. In addition, it presents the equation devised to calculate the likely price of the cell invasion and migration assays based upon its characteristics.

One of the key objectives of the report was to estimate the existing market size and estimate the future size of cell invasion and migration assays market. We have provided informed estimates on the evolution of the market, over the period 2022-2035. Our year-wise projections of the current and future opportunity have further been segmented on the basis of [A] type of assay (cell invasion assay and cell migration assay), [B] application area (drug discovery, screening and tumor study), [C] detection method used (colorimetry and fluorometry) and [D] key geographical regions (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World). In order to account for future uncertainties associated with some of the key parameters and to add robustness to our forecast model, we have provided three market forecast scenarios, portraying the conservative, base and optimistic tracks of the market’s evolution.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. Financial figures mentioned in this report are in USD, unless otherwise specified.

MARKET SEGMENTATIONS

Cell Invasion and Migration Assays: Market Segmentations

Market Segments Details

Forecast Period

• 2022 - 2035

Type of Assay

• Cell Invasion Assay
• Cell Migration Assay

Application Area

Drug Discovery

• Screening
• Tumor Study

Detection Method Used

• Colorimetry
• Fluorometry

Key Geographical Regions

• North America
• Europe
• Asia-Pacific
• MENA
• Latin America
• Rest of the World

Source: Roots Analysis

RESEARCH METHODOLOGY

The data presented in this report has been gathered via secondary research. For most of our projects, we conduct interviews with various experts in this domain (academia, industry, medical practice and other associations) in order to solicit their opinions on emerging trends in the market. This is primarily useful for us to draw out our own opinion on how the market will evolve across different regions and technology segments. Where possible, the available data has been checked for accuracy from multiple sources of information.

The secondary sources of information include:

• Annual reports
• Investor presentations
• SEC filings
• Industry databases
• News releases from company websites
• Government policy documents
• Industry analysts’ views

While the focus has been on forecasting the market till 2035, the report also provides our independent view on various technological and non-commercial trends emerging in the industry. This opinion is solely based on our knowledge, research and understanding of the relevant market gathered from various secondary and primary sources of information.

KEY QUESTIONS ANSWERED

• Which companies are engaged in offering cell invasion and migration assays kits?
• What is the most common assay format (in terms of number of wells) offered by cell invasion and migration assay providers?
• What are the key geographical regions where cell invasion and migration assay providers are located?
• What is the evolving trend of publications focused on cell invasion and migration assays?
• Which companies are actively filing patents to drive innovation in the field of cell invasion and migration assays?
• What are the key factors influencing the price of cell invasion and migration assays?
• What are the key challenges associated with cell invasion and migration assays?
• How is the current and future market opportunity likely to be distributed across key market segments?

CHAPTER OUTLINES

Chapter 2 is an executive summary of key insights captured during our research. It offers a high-level view on the current state of cell invasion and migration assays market and its likely evolution in the short to mid-term and long-term.

Chapter 3 provides a general introduction to cell invasion and migration, including a discussion on the Boyden Chamber’s principle. It further highlights different types of cell invasion and migration assays, along with information on the key challenges associated with this domain. Furthermore, it provides information on the role of kit components in cell invasion and migration assays and their various applications.

Chapter 4 provides a detailed assessment of the current market landscape of companies engaged in offering cell invasion and migration assays based on several parameters, such as year of establishment, company size, location of headquarters, type of end-user (industry and non-industry). It is worth highlighting that during our research, we were able to identify 83 cell invasion and migration assays that were assessed on various relevant parameters, such as type of cell culture (adherent cell culture and suspension cell culture), type of assay (cell invasion assay and cell migration assay), number of wells (24-well, 32-well, 48-well, 96-well and 384-well), pore size of wells (3 µm, 5 µm , 8 µm , 9 µm and 12 µm), type of ECM coating (basement membrane extract, collagen I, collagen IV, fibronectin and laminin,), storage temperature (ultra-low, frozen, refrigerated and room temperature), application area (drug discovery, screening and tumor study), detection method used (colorimetry and fluorometry) and number of assays performed.

Chapter 5 provides an insightful product competitiveness analysis, highlighting the capabilities of cell invasion and migration assay kit providers, based on supplier strength (in terms of years of experience and company size) and product portfolio strength (taking into account type of cell culture, number of wells, type of ECM coating, kit components, application area, detection method used and number of assays performed).

Chapter 6 provides elaborate profiles of key players (large and mid-sized companies, established before 2000) offering cell-based assay products. Each profile features a brief overview of the company, along with information on its product portfolio, recent developments and an informed future outlook.

Chapter 7 provides a detailed review of around 675 peer-reviewed, scientific articles related to research on cell invasion and migration assays, based on several relevant parameters, such as year of publication, type of publication, and popular keywords, top journals, top institutes and top authors (in terms of number of articles published).

Chapter 8 presents an analysis of patents related to cell invasion and migration assays, filed / granted since 2017, based on several relevant parameters, such as publication year, geographical location / patent jurisdiction, legal status, CPC symbols, emerging focus areas, type of applicant and leading players (in terms of number of patents). In addition, it features a patent valuation analysis, which evaluates the qualitative and quantitative aspects of patents.

Chapter 9 presents an analysis on academic grants that have been awarded to various research institutes for projects focused on cell invasion and migration, during the period, 2017-2022, based on several relevant parameters, such as year of grant award, amount awarded, support period, type of funding institute center and support period, grant application, purpose of grant award, grant activity code, NIH spending category, study section involved, popular NIH departments, recipient organization, regional distribution of recipient organization. Further, the chapter also highlights the popular recipient organizations, (in terms of number of grants and amount awarded) and prominent program officers.

Chapter 10 presents a Bowman’s strategy clock framework to understand the pricing strategy of the cell invasion and migration assays offered by a company, along with its competitive position. In addition, it presents the equation devised to calculate the likely price of the cell invasion and migration assays based upon its characteristics.

Chapter 11 presents an insightful market forecast analysis, highlighting the future potential of cell invasion and migration assays market till 2035. We have segmented the market on the basis of type of assay (cell invasion assay and cell migration assay), application area (drug discovery, screening and tumor study), detection method used (colorimetry and fluorometry) and key geographical regions (North America, Europe, Asia-Pacific, Latin America, MENA and Rest of the World).

Chapter 12 is a summary of the entire report. It provides the key takeaways and presents our independent opinion of the cell invasion and migration assays market, based on the research and analysis described in the previous chapters.

Chapter 13 is an appendix, which provides tabulated data and numbers for all the figures provided in the report.

Chapter 14 is an appendix, which provides the list of companies and organizations mentioned in the report.